Trial Profile
A tolerability, pharmacokinetics and phamacodynamics phase I clinical study of single-dose intravenous infusions of r-RGD-hirudin in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Dec 2016
Price :
$35
*
At a glance
- Drugs Hirudin (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 05 Jun 2014 New trial record